Divisional Update: Women Mar 2008

advertisement

CRRT Prescription

Akash Deep

Director - PICU

King ’s College Hospital

London

Chair

Renal/CRRT Section

European Society of Pediatric and

Neonatal Intensive Care (ESPNIC)

0

Overview

Vascath

Size , location

Rates & Dose

Blood flow

Dialysis fluid

Replacement fluid

Ultrafiltration rate

Anticoagulation

Drug Dose

Suggested

Not necessarily a recipe

Is there a “typical” prescription?

• CRRT for AKI or Sepsis or Liver failure

– does the dose matter ?

• Modality : Do you do convective or diffusive or both , does it matter?

• Blood Flow rate: based upon the size of the child or what the vascular access can give you?

• Anticoagulation – Which, when, dose, mode of delivery

• Drug dosing – a perennial debate!!!!

Essential steps in CRRT Prescription

• Decide the Indication to start CRRT

• PRESCRIBE:

 VASCULAR ACCESS – Size Location

 Haemofilter and appropriate Sized Blood line set

 Priming Solution

 Blood Flow

 Modality /Dose – Replacement Fluid/Dialysis Fluid

 Prescribe Fluid loss rate

 Prescription of electrolyte corrections

 Anticoagulation – Dose,Modality, Monitoring

 Drug Dosing

Blood flow rate

 Qb

 Age & weight

– based

 Promote circuit lifespan + patient stability: clots vs alarms

 Highly access-dependent

 Aim return access pressures ~ < 200 mmHg, no alarms

 Start lower and increase by about 10 minutes (?) – 50% of target and then go up 10% every 10 minutes till desired flow reached

Blood flow rate

 No set “perfect rates”

 From 3 to ~10 ml/kg/min, depending on age though we use minimum of 50 mls/min for newborns

 Examples:

0-10 kg:

11-20kg:

21-50kg:

>50kg:

25-50ml/min

80-100ml/min

100-150ml/min

150-180ml/min

Based on previously most commonly used machine

 Neonates 8 to 12 ml/kg/min

 Children 4 to 8 ml/kg/min

 Older 2 to 4 ml/kg/min.

 Most not > 200 ml/min: not dangerous just not necessary

Blood flow rate

May need to modify:

 - Patient hemodynamics – initial and subsequent

 which might change with CRRT

 - Be aware of access and return pressure

 - Visually inspect filter for clots

 - Trans-membrane pressure

– may need to increase blood flow

Treatment Dose

Dialysis and Replacement Fluid Rates:

Clearance & Dose

 Clearance mostly a function of:

 Dialysis fluid flow rate (Qd)

 Replacement fluid flow rate (Qr)

 Molecular weight and sieving coefficient

Qd + Qr (CVVHDF)

 Higher rates

= higher clearance for IEM, drug removal, severe high K

= more middle molecule clearance (CVVH/CVVHDF)

= more hypophosphatemia, kalaemia, magnesaemia

= more amino acid losses

= more drug clearance

= more work to change bags, give electrolyte infusions

Dialysis and Replacement Fluid Rates:

Clearance & Dose

 No well-defined right “dose” of clearance.

 For CRRT: mostly expressed in terms of effluent (ml/kg) per hour

“Standard” suggestion:

Qd or Qr or Qd+Qr ~ 40-60 ml/kg/hour

Urea clearance

~ 30-40 ml/min/1.73msq

OR 2 to 2.5 liters/hr/1.73msq.

Some do much higher: some machines as high as 8L/hour

REALIZE:

What you prescribe is not necessarily what the patient gets!!

Time off circuit, microclots in filter over time, predilution

Prescribed and Delivered therapy dose

• Typically, therapy dose would be prescribed at 35 ml/kg/hr , in practice the delivered therapy dose was on average 8ml/kg/hr less .

• Prescription should exceed that calculated to be adequate because of the known gap.

• Why might we ‘ lose ’ significant amounts of therapy dose?

– Recirculation in vascular access

– High filtration fractions

– Filter clogging and clotting

– Troubleshooting skills

– Changing of circuits

– Filter down time

Vesconi et al Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury Crit care 2009 13 (2);r57

CVVH

Qr = 300 ml/hour

CVVHDF

Qd = 150ml/hour

Qr = 150 ml/hour

CVVHD

Qd = 300 ml/hour

10 kg child: 30 ml/kg/hr “clearance”

OR ~ 0.26 msq: 2L/1.73msq/hour = 300 ml/hour

Dialysis Dose and Outcome

Ronco et al. Lancet 2000; 351: 26-30

425 patients

Endpoint = survival 15 days after D/C HF

146 UF rate 20ml/kg/hr survival significantly lower in this group compared to the others

139 UF rate 35ml/kg/hr p=0.0007

140 UF rate 45ml/kg/hr p=0.0013

Conclusions:

Minimum UF rates should be ~ 35 ml/kg/hr

Survivors had lower BUNs than non-survivors prior to commencement of hemofiltration

ATN Study

Randomised Evaluation of Normal vs Augmented

Level Replacement (RENAL) Therapy )

1500 critically ill adults

CVVHDF

25 ml/kg/hour

40 ml/kg/hour

Mortality at 28 days was similar in the higherintensity and lower-intensity treatment groups

(38.5% and 36.9%, respectively), and mortality at 90 days was the same (44.7%) in both groups.

Does the dose of solution exposure per unit of time matter

• These adult studies have failed to note a dose response curve of survival

• These studies are flawed for IHD vs CRRT was compared and CRRT was both convective and diffusive

So

• If you start with a standard prescription

• Eg

– BFR 5-10 mls/kg/min (access dependent)

– Membrane surface area proportional to patient body surface area

– Decision of convective or diffusive at approx

2000-3000/mls/hr/1.73m2

and

• If the marker of your clearance is not achieved

– E.g.

• inadequate clearance of Urea, Ammonia, intoxicant, lactate

• Then increase your solution exposure per unit of time

• Maximize convective clearance before adding diffusive clearance

• Consider increasing the BFR and increasing surface area of the membrane

• Filter downtimes to be minimised

Solutions

 CVVHD – dialysis fluid for diffusive clearance

 CVVH – replacement fluid:

 replacing fluid you are removing to achieve solute clearance by convection

 CVVHDF – both

 Priming solutions – Saline /blood prime

 Anticoagulant solutions

Using these to correct metabolic abnormalities (remove) and prevent treatment-related metabolic abnormalities (replace).

Dialysis fluid? Replacement fluid?

 Personal suggestion: use the same solution

 If needed (e.g. alkalosis) can modify the replacement solution

 Regulatory issues may hinder:

 Replacement solution – saline, with additives

Solutions: watch for errors!

Barletta et al, Pediatr Nephrol, 2006

Survey: ICU, Nephrology, CRRT

 16/31 programs reported solution compounding errors with manually dispensed solutions

 2 deaths

 1 non lethal cardiac arrest

 6 seizures (hypo/hypernatremia)

 7 without complications

Ultrafiltration/fluid removal Rates

 No Study has identified effective, safe UF rates in Children.

 General acceptance that 1-2ml/kg/hr is often safe (stable patient)

 Choose UF rate to:

 - balance input (e.g. boluses, citrate, calcium, etc)

 - remove excess fluid over time

 “make room” for IV fluids and nutrition

 - Also provides solute clearance by convection

Ultrafiltration/fluid removal Rates

 Fluid removal should be safe AND effective – no need to sacrifice one for other:

Frequent communication

– Frequent reassessment (MD), Hourly reassessment

(RN)

 Know what the

“usual hourly input is”:

» IV fluids

» Citrate & calcium

» Nutrition (give!!)

» Meds/infusions

» Provide “rules” for removing “intermittent fluids”

Be aware of the “outs” (tubes, urine, diarrhea)

Decide desired DAILY fluid removal based on:

 Haemodynamics

 TOTAL severity of Fluid Overload

SINGLE PASS Albumin dialysis -SPAD

 Removes protein bound small substances:

 e.g. copper/Wilson's, drugs, toxins of liver failure

 Albumin live a scavenger

Dialysis :

 albumin-containing solution across highly permeable membrane

 20% albumin NOT “added” to dialysis fluid bag- it sinks however it is mixed with normal dialysate via 3 way tap -it's “single pass”

- bags are changed

 Shouldn't affect sodium – may affect (reduce) other electrolytes

Collins et al, Pediatr Nephrol, 2008

Askenazi et al, Pediatrics, 2004

Ringe, Pediatr Crit Care Med, 2011

ANTICOAGULATION

ANTICOAGULATION-Points to consider

• Choice of anticoagulant

• Dose

• Route of delivery – systemic, into the circuit

• Heparin

• Citrate

• Prostacyclin

Anticoagulation

Dosing and Route

• Heparin – 10-20 U/kg/hour

• Prostacyclin – 2-8 ng/kg/min

• Citrate – separate protocol

• All anticoagulants to be used pre-filter with post filter monitoring ( ACT in heparin, ionised Ca in citrate)

Drug Dose Alteration

Drug dosing- important ( antibiotics, anticonvulsants, sedation, inotropes)

Hepatic failure + CRRT – Bigger issues

Based on:

– Protein Binding Information

Volume of Distribution

– Molecular Weight

Drug Prescribing in Renal Failure edited by George Aronoff et al

• Commonly carried text by pharmacists

• http://www.kdpbaptist.louisville.edu/renalbo ok/

• New edition to come out soon

• Recommendations for new drugs

• IHD and CRRT recommendations

• Pediatric recommendations

(T bunchman)

Summary

 Blood flow: balance access/circuit life with tolerability

 Solutions: Many choices

» Know their content, regional rules, CRRT type used

» Decide on desired flexibility

» Decide what's best for your institution (volume, expertise)

»

Bicarbonate and calcium are most substantial differences

» Be aware of errors – can be life threatening

 Dialysis/replacement fluid rates: ie clearance dose

» Balance desired clearance with undesired losses

» 2-2.5 L/hour/1.73msq – suggested only

Ultrafiltration rate:

» Frequent reassessment, team + targeted fluid removal decisions

»

Safety AND efficacy are feasible

Acknowledgements

T Bunchman

pCRRT Foundation

CRRT team at King ’s

Download